Mahsa Ghovvati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mahsa Ghovvati has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Nasim Annabi
Department of Chemical Engineering, Northeastern University, Boston, MA, 02115, USA; Biomaterials Innovation Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA
8 shared publications - Naoki Kaneko
David Geffen School of Medicine at UCLA
4 shared publications - Avijit Baidya
Department of Chemical and Biomolecular Engineering University of California, Los Angeles Los Angeles CA 90095 USA
2 shared publications Azadeh Mostafavi
Department of Chemical and Biomolecular Engineering University of California – Los Angeles Los Angeles California USA
2 shared publications- Kaavian Shariati
Division of Plastic and Reconstructive Surgery, Department of Surgery, UCLA David Geffen School of Medicine, Los Angeles, California
2 shared publications Reza Dana
Schepens Eye Research Institute, Mass Eye and Ear, Department of Ophthalmology Harvard Medical School Boston Massachusetts USA
2 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Elsevier in Materials & Design
- Vol. 271
Engineering tunable Elastin-Like Polypeptide/PEGDA composite hydrogels as injectable soft tissue fillers
- 29 September 2026
- Published by Elsevier in Materials & Design
- Vol. 271
Open AccessEngineering tunable Elastin-Like Polypeptide/PEGDA composite hydrogels as injectable soft tissue fillers
- Open Access
- 1 October 2025
- Published by Springer Nature in Cardiovascular Engineering and Technology
- Vol. 16 (6) , 703-713
Enhancing Stroke Prevention in Transcatheter Aortic Valve Replacement: The Role of F2, a Novel Neuroprotection Device
Purpose: Transcatheter aortic valve replacement (TAVR) is an established treatment for severe aortic stenosis; however, it carries the risk of periprocedural strokes. Current cerebral embolic protection (CEP) devices, such as the Sentinel, provide partial protection but are limited by inadequate anatomical coverage and inability to capture smaller emboli effectively. This study aimed to evaluate the effectiveness of a novel CEP device, the F2 filter with a 28 μm pore size and full cervical vessel coverage, in preventing emboli from entering the cerebral circulation. Methods: The Sentinel and F2 filter were evaluated for the ability to prevent embolic particles of various sizes (45-300 µm) from entering cerebral arteries using two in vitro flow models, incorporating standard and tortuous aortic anatomies. Additionally flow rates were also measured to confirm that normal perfusion was maintained while the devices were in place. Results: The F2 filter maintained normal cerebral arterial flow and significantly reduced the number of particles across all sizes compared to the Sentinel and control groups. This reduction was observed in all four cerebral branches and across both standard and tortuous aorta models. Conclusions: The F2 filter showed superior neuroprotective effectiveness to prevent embolic debris from entering the cerebral circulation in the in vitro models. By offering comprehensive coverage to all cervical arteries and with a smaller mesh size, this filter has the potential to improve cerebral protection during TAVR.
- 1 October 2025
- Published by Springer Nature in Cardiovascular Engineering and Technology
- Vol. 16 (6) , 703-713
Open AccessEnhancing Stroke Prevention in Transcatheter Aortic Valve Replacement: The Role of F2, a Novel Neuroprotection Device
Purpose: Transcatheter aortic valve replacement (TAVR) is an established treatment for severe aortic stenosis; however, it carries the risk of periprocedural strokes. Current cerebral embolic protection (CEP) devices, such as the Sentinel, provide partial protection but are limited by inadequate anatomical coverage and inability to capture smaller emboli effectively. This study aimed to evaluate the effectiveness of a novel CEP device, the F2 filter with a 28 μm pore size and full cervical vessel coverage, in preventing emboli from entering the cerebral circulation. Methods: The Sentinel and F2 filter were evaluated for the ability to prevent embolic particles of various sizes (45-300 µm) from entering cerebral arteries using two in vitro flow models, incorporating standard and tortuous aortic anatomies. Additionally flow rates were also measured to confirm that normal perfusion was maintained while the devices were in place. Results: The F2 filter maintained normal cerebral arterial flow and significantly reduced the number of particles across all sizes compared to the Sentinel and control groups. This reduction was observed in all four cerebral branches and across both standard and tortuous aorta models. Conclusions: The F2 filter showed superior neuroprotective effectiveness to prevent embolic debris from entering the cerebral circulation in the in vitro models. By offering comprehensive coverage to all cervical arteries and with a smaller mesh size, this filter has the potential to improve cerebral protection during TAVR.
- Open Access
- 30 June 2025
- Published by SAGE Publications in Interventional Neuroradiology
Microguidewire stiffness for microcatheter and aspiration catheter navigation in tortuous vessels
Background: Effective catheter navigation and trackability are crucial in neuroendovascular procedures, particularly through tortuous vessels where catheter kickback can potentially delay treatment and worsen patient outcomes. While operational experience suggests that stiffer microguidewires enhance catheter navigation and trackability, this relationship has not been experimentally validated. This study assesses the impact of microguidewire stiffness on targeted catheter delivery using in-vitro vascular models with severe tortuosity. Methods: Two experiments were conducted using silicone models of the intracranial vasculature to evaluate microguidewires of similar composition but differing stiffness, as defined by greater resistance to bending with the Stryker Synchro Select Soft, Standard, and Support microguidewires. In Experiment 1, 0.021″ microcatheter navigation through an acute angle M2 branch of the middle cerebral artery was assessed. In Experiment 2, 0.071″ aspiration catheter navigation through a severely tortuous internal carotid artery model was tested. Maximum catheter pushing force and microguidewire kickback length were measured in both experiments. Results: Stiffer microguidewires required significantly lower pushing forces and exhibited reduced microwire kickback during both microcatheter and aspiration catheter advancement. Conclusions: Microguidewire stiffness significantly influences neuroendovascular catheter deliverability. Stiffer microguidewires provide greater system stability, particularly at the distal end, enhancing catheter navigation and advancement through tortuous anatomy.
- 30 June 2025
- Published by SAGE Publications in Interventional Neuroradiology
Open AccessMicroguidewire stiffness for microcatheter and aspiration catheter navigation in tortuous vessels
Background: Effective catheter navigation and trackability are crucial in neuroendovascular procedures, particularly through tortuous vessels where catheter kickback can potentially delay treatment and worsen patient outcomes. While operational experience suggests that stiffer microguidewires enhance catheter navigation and trackability, this relationship has not been experimentally validated. This study assesses the impact of microguidewire stiffness on targeted catheter delivery using in-vitro vascular models with severe tortuosity. Methods: Two experiments were conducted using silicone models of the intracranial vasculature to evaluate microguidewires of similar composition but differing stiffness, as defined by greater resistance to bending with the Stryker Synchro Select Soft, Standard, and Support microguidewires. In Experiment 1, 0.021″ microcatheter navigation through an acute angle M2 branch of the middle cerebral artery was assessed. In Experiment 2, 0.071″ aspiration catheter navigation through a severely tortuous internal carotid artery model was tested. Maximum catheter pushing force and microguidewire kickback length were measured in both experiments. Results: Stiffer microguidewires required significantly lower pushing forces and exhibited reduced microwire kickback during both microcatheter and aspiration catheter advancement. Conclusions: Microguidewire stiffness significantly influences neuroendovascular catheter deliverability. Stiffer microguidewires provide greater system stability, particularly at the distal end, enhancing catheter navigation and advancement through tortuous anatomy.
- 14 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (798) , eadr6458
Rapid closure and hemostasis of ruptured soft tissues using a modified human tropoelastin-based sealant in preclinical models
Treatment of injuries to soft elastic organs is often hindered by challenging anatomical features and limitations of existing sealant materials, which may lack adequate tissue adhesion, elasticity, biocompatibility, and effective hemostatic properties. To address these clinical challenges, we developed an injectable elastic sealant formulated with methacryloyl-modified human recombinant tropoelastin (MeTro) and Laponite silicate nanoplatelets (SNs). We optimized the hydrogel formulation for mechanical properties, adhesion, biocompatibility, and hemostatic properties and used visible light for cross-linking to improve safety. MeTro/SN hydrogels had increased tissue adhesion strength and burst pressure in vitro and ex vivo compared with MeTro alone or commercial sealants. The addition of SNs to the hydrogels facilitated faster blood clotting in vitro without increasing hemolysis. Applied to incisional injuries on rat lungs or aortas, MeTro/SN had burst pressures comparable to those of native tissue and greater than those of MeTro after a 7-day in vivo application. On porcine lungs, MeTro/SN also supported effective lung sealing and burst pressure similar to native lung 14 days after injury sealing. In a rodent tail hemostasis model, MeTro/SN reduced bleeding compared with MeTro. In an injured porcine lung model, early hemostasis was better than the tested commercial sealants. The results demonstrated that MeTro/SN provided effective tissue sealing and promoted hemostasis in a time frame that minimized blood loss without causing a major inflammatory response. These findings highlight the translational potential of our engineered sealant with biomimetic mechanics, durable tissue adhesion, and rapid hemostasis as a multipronged approach for the sealing and repair of traumatic injuries to soft organs.
- 14 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (798) , eadr6458
Rapid closure and hemostasis of ruptured soft tissues using a modified human tropoelastin-based sealant in preclinical models
Treatment of injuries to soft elastic organs is often hindered by challenging anatomical features and limitations of existing sealant materials, which may lack adequate tissue adhesion, elasticity, biocompatibility, and effective hemostatic properties. To address these clinical challenges, we developed an injectable elastic sealant formulated with methacryloyl-modified human recombinant tropoelastin (MeTro) and Laponite silicate nanoplatelets (SNs). We optimized the hydrogel formulation for mechanical properties, adhesion, biocompatibility, and hemostatic properties and used visible light for cross-linking to improve safety. MeTro/SN hydrogels had increased tissue adhesion strength and burst pressure in vitro and ex vivo compared with MeTro alone or commercial sealants. The addition of SNs to the hydrogels facilitated faster blood clotting in vitro without increasing hemolysis. Applied to incisional injuries on rat lungs or aortas, MeTro/SN had burst pressures comparable to those of native tissue and greater than those of MeTro after a 7-day in vivo application. On porcine lungs, MeTro/SN also supported effective lung sealing and burst pressure similar to native lung 14 days after injury sealing. In a rodent tail hemostasis model, MeTro/SN reduced bleeding compared with MeTro. In an injured porcine lung model, early hemostasis was better than the tested commercial sealants. The results demonstrated that MeTro/SN provided effective tissue sealing and promoted hemostasis in a time frame that minimized blood loss without causing a major inflammatory response. These findings highlight the translational potential of our engineered sealant with biomimetic mechanics, durable tissue adhesion, and rapid hemostasis as a multipronged approach for the sealing and repair of traumatic injuries to soft organs.
- Top Cited Papers
Smart Mesoporous Silica Nanoparticles in Cancer: Diagnosis, Treatment, Immunogenicity, and Clinical Translation
In cancer research and personalized medicine, mesoporous silica nanoparticles (MSNs) have emerged as a significant breakthrough in both cancer treatment and diagnosis. MSNs offer targeted drug delivery, enhancing therapeutic effectiveness while minimizing adverse effects on healthy cells. Due to their unique characteristics, MSNs provide targeted drug delivery, maximizing therapeutic effectiveness with minimal adverse effects on healthy cells. The review thoroughly investigates the role of MSNs as potent drug carriers, noted for their high drug‐loading capacity and controlled release, which significantly improves drug permeability and retention. Additionally, it discusses surface modification techniques that enable MSNs to target cancer cells precisely. The manuscript provides comprehensive insights into various MSN applications, including their role in cancer diagnosis, the design of advanced biosensors, and the development of both conventional and stimuli‐responsive drug delivery platforms. Special focus is given to stimuli‐triggered MSN systems, responsive to internal stimuli (e.g., pH, redox, enzyme) and external stimuli (e.g., temperature, magnetic field, light, ultrasound), highlighting the cutting‐edge progress in MSN technology. Additionally, the review delves into the immunogenicity and biosafety aspects of MSNs, underscoring their potential for clinical translation. Besides summarizing the current state of MSN research in oncology, this review also illuminates the path for future advancements and clinical applications.
Top Cited PapersSmart Mesoporous Silica Nanoparticles in Cancer: Diagnosis, Treatment, Immunogenicity, and Clinical Translation
In cancer research and personalized medicine, mesoporous silica nanoparticles (MSNs) have emerged as a significant breakthrough in both cancer treatment and diagnosis. MSNs offer targeted drug delivery, enhancing therapeutic effectiveness while minimizing adverse effects on healthy cells. Due to their unique characteristics, MSNs provide targeted drug delivery, maximizing therapeutic effectiveness with minimal adverse effects on healthy cells. The review thoroughly investigates the role of MSNs as potent drug carriers, noted for their high drug‐loading capacity and controlled release, which significantly improves drug permeability and retention. Additionally, it discusses surface modification techniques that enable MSNs to target cancer cells precisely. The manuscript provides comprehensive insights into various MSN applications, including their role in cancer diagnosis, the design of advanced biosensors, and the development of both conventional and stimuli‐responsive drug delivery platforms. Special focus is given to stimuli‐triggered MSN systems, responsive to internal stimuli (e.g., pH, redox, enzyme) and external stimuli (e.g., temperature, magnetic field, light, ultrasound), highlighting the cutting‐edge progress in MSN technology. Additionally, the review delves into the immunogenicity and biosafety aspects of MSNs, underscoring their potential for clinical translation. Besides summarizing the current state of MSN research in oncology, this review also illuminates the path for future advancements and clinical applications.
- Open Access
- 3 May 2024
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 9 (5) , e10667
A stretchable, electroconductive tissue adhesive for the treatment of neural injury
Successful nerve repair using bioadhesive hydrogels demands minimizing tissue–material interfacial mechanical mismatch to reduce immune responses and scar tissue formation. Furthermore, it is crucial to maintain the bioelectrical stimulation‐mediated cell‐signaling mechanism to overcome communication barriers within injured nerve tissues. Therefore, engineering bioadhesives for neural tissue regeneration necessitates the integration of electroconductive properties with tissue‐like biomechanics. In this study, we propose a stretchable bioadhesive based on a custom‐designed chemically modified elastin‐like polypeptides (ELPs) and a choline‐based bioionic liquid (Bio‐IL), providing an electroconductive microenvironment to reconnect damaged nerve tissue. The stretchability akin to native neural tissue was achieved by incorporating hydrophobic ELP pockets, and a robust tissue adhesion was obtained due to multi‐mode tissue–material interactions through covalent and noncovalent bonding at the tissue interface. Adhesion tests revealed adhesive strength ~10 times higher than commercially available tissue adhesive, Evicel®. Furthermore, the engineered hydrogel supported in vitro viability and proliferation of human glial cells. We also evaluated the biodegradability and biocompatibility of the engineered bioadhesive in vivo using a rat subcutaneous implantation model, which demonstrated facile tissue infiltration and minimal immune response. The outlined functionalities empower the engineered elastic and electroconductive adhesive hydrogel to effectively enable sutureless surgical sealing of neural injuries and promote tissue regeneration.
- 3 May 2024
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 9 (5) , e10667
Open AccessA stretchable, electroconductive tissue adhesive for the treatment of neural injury
Successful nerve repair using bioadhesive hydrogels demands minimizing tissue–material interfacial mechanical mismatch to reduce immune responses and scar tissue formation. Furthermore, it is crucial to maintain the bioelectrical stimulation‐mediated cell‐signaling mechanism to overcome communication barriers within injured nerve tissues. Therefore, engineering bioadhesives for neural tissue regeneration necessitates the integration of electroconductive properties with tissue‐like biomechanics. In this study, we propose a stretchable bioadhesive based on a custom‐designed chemically modified elastin‐like polypeptides (ELPs) and a choline‐based bioionic liquid (Bio‐IL), providing an electroconductive microenvironment to reconnect damaged nerve tissue. The stretchability akin to native neural tissue was achieved by incorporating hydrophobic ELP pockets, and a robust tissue adhesion was obtained due to multi‐mode tissue–material interactions through covalent and noncovalent bonding at the tissue interface. Adhesion tests revealed adhesive strength ~10 times higher than commercially available tissue adhesive, Evicel®. Furthermore, the engineered hydrogel supported in vitro viability and proliferation of human glial cells. We also evaluated the biodegradability and biocompatibility of the engineered bioadhesive in vivo using a rat subcutaneous implantation model, which demonstrated facile tissue infiltration and minimal immune response. The outlined functionalities empower the engineered elastic and electroconductive adhesive hydrogel to effectively enable sutureless surgical sealing of neural injuries and promote tissue regeneration.
- Open Access
- 5 December 2023
- Published by Elsevier in Trends in Biotechnology
- Vol. 42 (5) , 544-559
Advances in 3D bioprinting for urethral tissue reconstruction
- 5 December 2023
- Published by Elsevier in Trends in Biotechnology
- Vol. 42 (5) , 544-559
Open AccessAdvances in 3D bioprinting for urethral tissue reconstruction
- Open Access
- 12 July 2023
- Published by Elsevier in Biomaterials
- Vol. 301, 122240
Hemostatic patch with ultra-strengthened mechanical properties for efficient adhesion to wet surfaces
- 12 July 2023
- Published by Elsevier in Biomaterials
- Vol. 301, 122240
Open AccessHemostatic patch with ultra-strengthened mechanical properties for efficient adhesion to wet surfaces
- 16 March 2023
- Published by Wiley in AIChE Journal
- Vol. 69 (6)
Engineering a drug eluting ocular patch for delivery and sustained release of anti‐inflammatory therapeutics
Ocular inflammation is commonly associated with eye disease or injury. Effective and sustained ocular delivery of therapeutics remains a challenge due to the eye physiology and structural barriers. Herein, we engineered a photocrosslinkable adhesive patch (GelPatch) incorporated with micelles (MCs) loaded with loteprednol etabonate (LE) for delivery and sustained release of drug. The engineered drug loaded adhesive hydrogel, with controlled physical properties, provided a matrix with high adhesion to the ocular surfaces. The incorporation of MCs within the GelPatch enabled solubilization of LE and its sustained release within 15 days. In vitro studies showed that MC loaded GelPatch supported cell viability and growth. In addition, subcutaneous implantation of the MC loaded GelPatch in rats confirmed its in vivo biocompatibility and stability within 28 days. This non‐invasive, adhesive, and biocompatible drug eluting patch can be used as a matrix for the delivery and sustained release of hydrophobic drugs.
- 16 March 2023
- Published by Wiley in AIChE Journal
- Vol. 69 (6)
Engineering a drug eluting ocular patch for delivery and sustained release of anti‐inflammatory therapeutics
Ocular inflammation is commonly associated with eye disease or injury. Effective and sustained ocular delivery of therapeutics remains a challenge due to the eye physiology and structural barriers. Herein, we engineered a photocrosslinkable adhesive patch (GelPatch) incorporated with micelles (MCs) loaded with loteprednol etabonate (LE) for delivery and sustained release of drug. The engineered drug loaded adhesive hydrogel, with controlled physical properties, provided a matrix with high adhesion to the ocular surfaces. The incorporation of MCs within the GelPatch enabled solubilization of LE and its sustained release within 15 days. In vitro studies showed that MC loaded GelPatch supported cell viability and growth. In addition, subcutaneous implantation of the MC loaded GelPatch in rats confirmed its in vivo biocompatibility and stability within 28 days. This non‐invasive, adhesive, and biocompatible drug eluting patch can be used as a matrix for the delivery and sustained release of hydrophobic drugs.
- 20 October 2022
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 11 (4) , 1318-1334
Development and optimization of an ocular hydrogel adhesive patch using definitive screening design (DSD)
Adhesive hydrogels based on chemically modified photocrosslinkable polymers with specific physicochemical properties are frequently utilized for sealing wounds or incisions. These adhesive hydrogels offer tunable characteristics such as tailorable tissue adhesion, mechanical properties, swelling ratios, and enzymatic degradability. In this study, we developed and optimized a photocrosslinkable adhesive patch, GelPatch, with high burst pressure, minimal swelling, and specific mechanical properties for application as an ocular (sclera and subconjunctival) tissue adhesive. To achieve this, we formulated a series of hydrogel patches composed of different polymers with various levels of methacrylation, molecular weights, and hydrophobic/hydrophilic properties. A computerized multifactorial definitive screening design (DSD) analysis was performed to identify the most prominent components impacting critical response parameters such as adhesion, swelling ratio, elastic modulus, and second order interactions between applied components. These parameters were mathematically processed to generate a predictive model that identifies the linear and non-linear correlations between these factors. In conclusion, an optimized formulation of GelPatch was selected based on two modified polymers: gelatin methacryloyl (GelMA) and glycidyl methacrylated hyaluronic acid (HAGM). The ex vivo results confirmed adhesion and retention of the optimized hydrogel subconjunctivally and on the sclera for up to 4 days. The developed formulation has potential to be used as an ocular sealant for quick repair of laceration type ocular injuries.
- 20 October 2022
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 11 (4) , 1318-1334
Development and optimization of an ocular hydrogel adhesive patch using definitive screening design (DSD)
Adhesive hydrogels based on chemically modified photocrosslinkable polymers with specific physicochemical properties are frequently utilized for sealing wounds or incisions. These adhesive hydrogels offer tunable characteristics such as tailorable tissue adhesion, mechanical properties, swelling ratios, and enzymatic degradability. In this study, we developed and optimized a photocrosslinkable adhesive patch, GelPatch, with high burst pressure, minimal swelling, and specific mechanical properties for application as an ocular (sclera and subconjunctival) tissue adhesive. To achieve this, we formulated a series of hydrogel patches composed of different polymers with various levels of methacrylation, molecular weights, and hydrophobic/hydrophilic properties. A computerized multifactorial definitive screening design (DSD) analysis was performed to identify the most prominent components impacting critical response parameters such as adhesion, swelling ratio, elastic modulus, and second order interactions between applied components. These parameters were mathematically processed to generate a predictive model that identifies the linear and non-linear correlations between these factors. In conclusion, an optimized formulation of GelPatch was selected based on two modified polymers: gelatin methacryloyl (GelMA) and glycidyl methacrylated hyaluronic acid (HAGM). The ex vivo results confirmed adhesion and retention of the optimized hydrogel subconjunctivally and on the sclera for up to 4 days. The developed formulation has potential to be used as an ocular sealant for quick repair of laceration type ocular injuries.